APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis

Abstract Background Immune checkpoint inhibitors (ICIs) are rapidly evolving in the management of bladder cancer (BLCA). Nevertheless, effective biomarkers for predicting immunotherapeutic outcomes in BLCA are still insufficient. Ferroptosis, a form of immunogenic cell death, has been found to enhan...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Zhiwei Fan, Yiting Liu, Xuehai Wang, Yuting Xu, Ruiyao Huang, Weijian Shi, Yi Qu, Jialing Ruan, Chu Zhou, Xinyuan Zhao, Lei Liu
Format:	Article
Language:	English
Published:	BMC 2024-08-01
Subjects:	APOL6 Bladder cancer (BLCA) Immunotherapy Ferroptosis
Online Access:	https://doi.org/10.1186/s12885-024-12820-7